Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung

• Published in: Human pathology 1997, Vol.28 (1), p.54-59
• Main Authors: Clarke, Martha R, Landreneau, Rodney J, Finkelstein, Sydney D, Wu, Tsung T, Ohori, Paul, Yousem, Samuel A
• Format: Article
• Language: English
• Subjects: Adenocarcinoma - metabolism; Adenocarcinoma - secondary; Adult; Aged; Aged, 80 and over; Biological and medical sciences; Collagen - biosynthesis; Collagenases - biosynthesis; Extracellular Matrix - metabolism; Humans; integrins; Integrins - biosynthesis; lung cancer; Lung Neoplasms - metabolism; Lung Neoplasms - pathology; Medical sciences; Middle Aged; Pneumology; Tumors of the respiratory system and mediastinum; type IV collagen; type IV collagenase
• ISSN: 0046-8177; 1532-8392
• DOI: 10.1016/S0046-8177(97)90279-3

Alterations in extracellular matrix, cell-cell and cell-matrix adhesion, and oncogenes are thought to be important in tumor progression and metastasis. Adenocarcinomas of the lung from 31 patients were studied for immunohistochemical expression of basement membrane molecule type IV collagen, type IV collagenase, and integrins α 2,3, v adhesion molecules to assess their diagnostic and prognostic importance in pathological stage T2 tumors. The results indicate that with decreasing tumor differentiation, there is a progressive loss of type IV basement membrane collagen ( P = .06) and decreased integrin α 2 expression ( P = .03). Type IV collagenase expression was significantly associated with the presence of lymph node metastases, with moderate to strong expression present in 53% T2N1 tumors compared with none (0%) of the T2N0 tumors ( P = .008). Integrin α v was increased in tumors with nodal metastases compared with those without ( P = .08). Loss of alpha 2 and alpha 3 integrins was associated with increased alpha v expression ( P = .03). Median survival was 48 months for T2N0 and 20 months for T2N1 ( P = .07). In correlating expression of the immunohistochemical markers and survival, type IV collagenase expression was found to be a predictor of survival at a level of P = .07. Measurable alterations in integrins and extracellular matrix, and in particular, expression of matrix-degrading enzyme type IV collagenase may be of prognostic importance in resectable adenocarcinoma of the lung.